List of bibliographic references indexed by Responder
Number of relevant bibliographic references: 97.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 002833 (2013) |
Kristian Thorlund [Canada] ; Eric Druyts [Canada] ; J Antonio Avi A-Zubieta [Canada] ; Ping Wu [Canada] ; Edward J. Mills [Canada] | Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings |
| 002834 (2013) |
Daniel E. Furst [États-Unis] ; Edward Clark Keystone [Canada] ; Alexander K. So [États-Unis, Canada, Allemagne, Pays-Bas, Italie, Royaume-Uni, Autriche] ; Jürgen Braun [Allemagne] ; Ferry C. Breedveld [Pays-Bas] ; Gerd R. Burmester [Italie] ; Fabrizio De Benedetti [Allemagne] ; Thomas Dörner [Allemagne] ; Paul Emery [Royaume-Uni] ; Roy Fleischmann [États-Unis] ; Allan Gibofsky [États-Unis] ; J R Kalden [Allemagne] ; Arthur Kavanaugh [États-Unis] ; Bruce Kirkham [Royaume-Uni] ; Philip Mease [États-Unis] ; A. Rubbert-Roth [Allemagne] ; Joachim Sieper [Allemagne] ; Nora G. Singer [États-Unis] ; Josef S. Smolen [Autriche] ; Piet L C M. Van Riel [Pays-Bas] ; Michael H. Weisman [États-Unis] ; Kevin L. Winthrop [États-Unis] | Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012 |
| 002838 (2013) |
Samantha Louise Smith [Royaume-Uni] ; Darren Plant [Royaume-Uni] ; Stephen Eyre [Royaume-Uni] ; Anne Barton [Royaume-Uni] | The potential use of expression profiling: implications for predicting treatment response in rheumatoid arthritis |
| 002840 (2013) |
Mark C. Genovese [États-Unis] ; Roy M. Fleischmann [États-Unis] ; Maria Greenwald [États-Unis] ; Julie Satterwhite [États-Unis] ; Melissa Veenhuizen [États-Unis] ; Li Xie [États-Unis] ; Pierre-Yves Berclaz [États-Unis] ; Stephen Myers [États-Unis] ; Olivier Benichou [États-Unis] | Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors |
| 002850 (2013) |
In-Ho Song [Allemagne] ; Frank Heldmann [Allemagne] ; Martin Rudwaleit [Allemagne] ; Joachim Listing [Allemagne] ; Heiner Appel [Allemagne] ; Iris Haug-Rost [Allemagne] ; Jürgen Braun [Allemagne] ; Joachim Sieper [Allemagne] | One-year follow-up of ankylosing spondylitis patients responding to rituximab treatment and re-treated in case of a flare |
| 002855 (2013) |
C. Malattia [Italie] ; A. Consolaro [Italie] ; S. Pederzoli [Italie] ; A. Madeo [Italie] ; A. Pistorio [Italie] ; M. Mazzoni [Italie] ; C. Mattiuz [Italie] ; Gm Magnano [Italie] ; S. Viola [Italie] ; A. Buoncompagni [Italie] ; E. Palmisani [Italie] ; R. Hasija [Italie] ; N. Ruperto [Italie] ; A. Ravelli [Italie] ; A. Martini [Italie] | MRI versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in juvenile idiopathic arthritis |
| 002894 (2013) |
Oliver Foot ; Anshuman Malaviya | Treatment of rheumatoid arthritis: current and future |
| 002A51 (2013) |
K. Ishii ; Y. Mochida ; K. Harigane ; Y. Yamada ; N. Mitsugi ; T. Saito [Japon] | THU0062 Analysis of perioperative clinical features and complications in patients with rheumatoid arthritis treated with biologic agents |
| 002A52 (2013) |
J. Back ; E. Baecklund [Suède] ; G. Birgegard [Suède] | THU0061 Anemia in patients with rheumatoid arthritis: A cross-sectional study |
| 002A53 (2013) |
J. Kur-Zalewska [Pologne] ; M. Tlustochowicz [Pologne] ; W. Tlustochowicz [Pologne] | THU0060 Risk factors of interstitial lung disease in patients with rheumatoid arthritis |
| 002A54 (2013) |
I. V. D. Oever ; M. T. Nurmohamed [Pays-Bas] | THU0059 Reduction of inflammation with abatacept and tocilizumab results in lower N-terminal pro brain natriuretic peptide levels in patients with rheumatoid arthritis: Results from two prospective cohort studies |
| 002B51 (2013) |
T. Takeuchi [Japon] ; Y. Tanaka ; K. Amano ; J. Kikuchi [Japon] ; E. Tanaka [Japon] ; S. Hirata ; H. Nagasawa ; H. Yasuoka [Japon] ; H. Yamanaka [Japon] | SAT0140 Effectiveness of Abatacept Against Rheumatoid Arthritis in Daily Clinical Practice - Orbit Study |
| 002B52 (2013) |
T. Kojima [Japon] ; N. Takahashi [Japon] ; K. Funahashi [Japon] ; D. Kato [Japon] ; Y. Hattori [Japon] ; M. Hanabayashi [Japon] ; N. Asai [Japon] ; N. Ishiguro [Japon] | SAT0139 Importance of Concomitant MTX Use During Treatment with Tocilizumab in Patients with Rheumatoid Arthritis |
| 002B75 (2013) |
M. W. Tang [Pays-Bas] ; D. M. Gerlag [Pays-Bas] ; V. Codullo [Pays-Bas] ; E. C. Vieina De Sousa [Pays-Bas] ; A. Q. Reuwer [Pays-Bas] ; M. Twickler [Pays-Bas] ; R. B. Landewé [Pays-Bas] ; P. P. Tak [Pays-Bas] | SAT0104 The role of prolactin, as sex hormone, and its receptor involved in rheumatoid arthritis |
| 002B77 (2013) |
M. Yoshimura ; Y. Maeda ; M. Katayama ; A. Watanabe ; E. Tanaka ; S. Tsuji ; Y. Harada ; Y. Katada ; M. Matsushita ; J. Hashimoto ; S. Ohshima [Japon] ; Y. Saeki [Japon] | SAT0103 The analysis of reasons of discontinuing biologics in japanese patients with rheumatoid arthritis; from the ninja (national database of rheumatic disease by IR-net in japan) |
| 002B80 (2013) |
L. Naumann [Allemagne] ; H. Bang ; K. Egerer ; D. Meyer Zum Büschenfelde ; B. Lehmann ; G. Fredenhagen ; H. Bastian [Allemagne] ; E. Wittenborn [Allemagne] ; G.-R. Burmester [Allemagne] ; E. Feist [Allemagne] | SAT0102 Epitope mapping for MCV peptides and subclass of anti-MCV antibodies is a useful tool for the prediction of response to B-cell directed therapy in rheumatoid arthritis |
| 002C36 (2013) |
| OS42: Interstitial Lung Disease 6 |
| 002C37 (2013) |
| OS41: Tuberculosis 5 |
| 002C38 (2013) |
| OS40: COPD 4 |
| 002C39 (2013) |
| OS39: Clinical Allergy & Immunology |
| 002C40 (2013) |
| OS38: Interstitial Lung Disease 5 |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Responder"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i \
-Sk "Responder" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Teeft.i
|clé= Responder
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 |  |
